Search Results - "De Alencastro, Gustavo"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex by de Alencastro, Gustavo, Puzzo, Francesco, Pavel-Dinu, Mara, Zhang, Feijie, Pillay, Sirika, Majzoub, Karim, Tiffany, Matthew, Jang, Hagoon, Sheikali, Adam, Cromer, M. Kyle, Meetei, Ruhikanta, Carette, Jan E., Porteus, Matthew H., Pekrun, Katja, Kay, Mark A.

    Published in Molecular therapy (03-03-2021)
    “…Recombinant adeno-associated virus (rAAV) vectors have the unique property of being able to perform genomic targeted integration (TI) without inducing a…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Collybistin and gephyrin are novel components of the eukaryotic translation initiation factor 3 complex by Sertie, Andrea L, de Alencastro, Gustavo, De Paula, Vanessa J, Passos-Bueno, Maria Rita

    Published in BMC research notes (21-09-2010)
    “…Collybistin (CB), a neuron-specific guanine nucleotide exchange factor, has been implicated in targeting gephyrin-GABAA receptors clusters to inhibitory…”
    Get full text
    Journal Article
  5. 5

    Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing by de Alencastro, Gustavo, Pekrun, Katja, Valdmanis, Paul, Tiffany, Matthew, Xu, Jianpeng, Kay, Mark A

    Published in Human gene therapy (01-05-2020)
    “…Despite early successes using recombinant adeno-associated virus (rAAV) vectors in clinical gene therapy trials, limitations remain making additional…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice by Tsuji, Shinnosuke, Stephens, Calvin J., Bortolussi, Giulia, Zhang, Feijie, Baj, Gabriele, Jang, Hagoon, de Alencastro, Gustavo, Muro, Andrés F., Pekrun, Katja, Kay, Mark A.

    Published in Nature biotechnology (01-08-2022)
    “…Homologous recombination (HR)-based gene therapy using adeno-associated viruses (AAV-HR) without nucleases has several advantages over classic gene therapy,…”
    Get full text
    Journal Article
  8. 8

    Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors by Pekrun, Katja, De Alencastro, Gustavo, Luo, Qing-Jun, Liu, Jun, Kim, Youngjin, Nygaard, Sean, Galivo, Feorillo, Zhang, Feijie, Song, Ren, Tiffany, Matthew R, Xu, Jianpeng, Hebrok, Matthias, Grompe, Markus, Kay, Mark A

    Published in JCI insight (14-11-2019)
    “…While gene transfer using recombinant adeno-associated viral (rAAV) vectors has shown success in some clinical trials, there remain many tissues that are not…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Exploiting the unique regenerative capacity of the liver to underpin cell and gene therapy strategies for genetic and acquired liver disease by Logan, Grant J., de Alencastro, Gustavo, Alexander, Ian E., Yeoh, George C.

    “…The number of genetic or acquired diseases of the liver treatable by organ transplantation is ever-increasing as transplantation techniques improve placing…”
    Get full text
    Journal Article
  11. 11
  12. 12